Candida infections in the intensive care unit

Epidemiology, risk factors and therapeutic strategies

Matteo Bassetti, Elda Righi, Mario Tumbarello, Antonio Di Biagio, Raffaella Rosso, Claudio Viscoli

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

This article reviews the epidemiology, predisposing risk factors and outcome of systemic Candida spp. infections in the intensive care unit setting. Incidence of systemic Candida infections in patients requiring intensive care has increased substantially in recent years; while diagnosis of serious Candida infection may be difficult, the clinical conditions which predispose patients to these infections are now better understood and effective antifungal therapies are becoming increasingly available. Severe fungal infections are generally associated with poor outcomes in these patients. Patients at highest risk for Candida infection may be potential candidates for early, presumptive therapy. In this article we review antifungal treatment, including the use of polyenes, azoles and echinocandines, and the role of prophylaxis.

Original languageEnglish
Pages (from-to)875-885
Number of pages11
JournalExpert Review of Anti-Infective Therapy
Volume4
Issue number5
DOIs
Publication statusPublished - Oct 2006

Fingerprint

Candida
Intensive Care Units
Epidemiology
Infection
Polyenes
Azoles
Mycoses
Therapeutics
Critical Care
Secondary Prevention
Causality
Incidence

Keywords

  • Antifungal therapy
  • Candidemia
  • Intensive care unit
  • Risk factors

ASJC Scopus subject areas

  • Infectious Diseases
  • Parasitology

Cite this

Candida infections in the intensive care unit : Epidemiology, risk factors and therapeutic strategies. / Bassetti, Matteo; Righi, Elda; Tumbarello, Mario; Di Biagio, Antonio; Rosso, Raffaella; Viscoli, Claudio.

In: Expert Review of Anti-Infective Therapy, Vol. 4, No. 5, 10.2006, p. 875-885.

Research output: Contribution to journalArticle

Bassetti, Matteo ; Righi, Elda ; Tumbarello, Mario ; Di Biagio, Antonio ; Rosso, Raffaella ; Viscoli, Claudio. / Candida infections in the intensive care unit : Epidemiology, risk factors and therapeutic strategies. In: Expert Review of Anti-Infective Therapy. 2006 ; Vol. 4, No. 5. pp. 875-885.
@article{6c6d2b6fd0794b178fe7211d4212f406,
title = "Candida infections in the intensive care unit: Epidemiology, risk factors and therapeutic strategies",
abstract = "This article reviews the epidemiology, predisposing risk factors and outcome of systemic Candida spp. infections in the intensive care unit setting. Incidence of systemic Candida infections in patients requiring intensive care has increased substantially in recent years; while diagnosis of serious Candida infection may be difficult, the clinical conditions which predispose patients to these infections are now better understood and effective antifungal therapies are becoming increasingly available. Severe fungal infections are generally associated with poor outcomes in these patients. Patients at highest risk for Candida infection may be potential candidates for early, presumptive therapy. In this article we review antifungal treatment, including the use of polyenes, azoles and echinocandines, and the role of prophylaxis.",
keywords = "Antifungal therapy, Candidemia, Intensive care unit, Risk factors",
author = "Matteo Bassetti and Elda Righi and Mario Tumbarello and {Di Biagio}, Antonio and Raffaella Rosso and Claudio Viscoli",
year = "2006",
month = "10",
doi = "10.1586/14787210.4.5.875",
language = "English",
volume = "4",
pages = "875--885",
journal = "Expert Review of Anti-Infective Therapy",
issn = "1478-7210",
publisher = "Taylor and Francis Ltd.",
number = "5",

}

TY - JOUR

T1 - Candida infections in the intensive care unit

T2 - Epidemiology, risk factors and therapeutic strategies

AU - Bassetti, Matteo

AU - Righi, Elda

AU - Tumbarello, Mario

AU - Di Biagio, Antonio

AU - Rosso, Raffaella

AU - Viscoli, Claudio

PY - 2006/10

Y1 - 2006/10

N2 - This article reviews the epidemiology, predisposing risk factors and outcome of systemic Candida spp. infections in the intensive care unit setting. Incidence of systemic Candida infections in patients requiring intensive care has increased substantially in recent years; while diagnosis of serious Candida infection may be difficult, the clinical conditions which predispose patients to these infections are now better understood and effective antifungal therapies are becoming increasingly available. Severe fungal infections are generally associated with poor outcomes in these patients. Patients at highest risk for Candida infection may be potential candidates for early, presumptive therapy. In this article we review antifungal treatment, including the use of polyenes, azoles and echinocandines, and the role of prophylaxis.

AB - This article reviews the epidemiology, predisposing risk factors and outcome of systemic Candida spp. infections in the intensive care unit setting. Incidence of systemic Candida infections in patients requiring intensive care has increased substantially in recent years; while diagnosis of serious Candida infection may be difficult, the clinical conditions which predispose patients to these infections are now better understood and effective antifungal therapies are becoming increasingly available. Severe fungal infections are generally associated with poor outcomes in these patients. Patients at highest risk for Candida infection may be potential candidates for early, presumptive therapy. In this article we review antifungal treatment, including the use of polyenes, azoles and echinocandines, and the role of prophylaxis.

KW - Antifungal therapy

KW - Candidemia

KW - Intensive care unit

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=33845416987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845416987&partnerID=8YFLogxK

U2 - 10.1586/14787210.4.5.875

DO - 10.1586/14787210.4.5.875

M3 - Article

VL - 4

SP - 875

EP - 885

JO - Expert Review of Anti-Infective Therapy

JF - Expert Review of Anti-Infective Therapy

SN - 1478-7210

IS - 5

ER -